Allergen-specific sublingual immunotherapy is dose and duration dependent in a murine allergic rhinitis model

J Allergy Clin Immunol. 2018 Dec;142(6):1977-1979.e9. doi: 10.1016/j.jaci.2018.08.002. Epub 2018 Aug 10.

Authors

Soichi Tofukuji¹, Kazufumi Katayama², Yoshiyuki Nakano¹, Satoru Ishida¹, Junji Tsuchida¹, Minako Tajiri¹, Yusuke Shimo¹, Hidekazu Tanaka¹, Michitaka Shichijo¹

Affiliations

¹ Drug Discovery & Disease Research Laboratory, Shionogi & Co, Ltd, Osaka, Japan.
² Drug Discovery & Disease Research Laboratory, Shionogi & Co, Ltd, Osaka, Japan. Electronic address: kazufumi.katayama@shionogi.co.jp.

PMID: 30102936
DOI: 10.1016/j.jaci.2018.08.002

No abstract available

Publication types

Letter

MeSH terms

Allergens / administration & dosage*
Animals
Cryptomeria / immunology*
Cytokines / immunology
Disease Models, Animal*
Female
Immunoglobulin G / blood
Mice, Inbred BALB C
Pollen / immunology
Rhinitis, Allergic, Seasonal / blood
Rhinitis, Allergic, Seasonal / immunology
Rhinitis, Allergic, Seasonal / therapy*
Sublingual Immunotherapy / methods*

Substances

Allergens
Cytokines
Immunoglobulin G